Inspire Medical Systems, Inc.
INSP · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $4 | $5 | $6 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $4 | $5 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.4% | 7.8% | -16% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 85.8% | 84% | 84.7% | 85% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 7.7% | 0.5% | 0.8% | 23.7% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 4.4% | -1.7% | 1.5% | 14.7% |
| EPS Diluted | 0.34 | -0.12 | 0.1 | 1.15 |
| % Growth | 383.3% | -220% | -91.3% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |